Today

Agents

Chat

Arena

Discover

More

App

INmune Bio schedules conference call to discuss Q2 2026 results - INMB News | Rallies

INmune Bio schedules conference call to discuss Q2 2026 results

INMB•2026-07-31

Conference call scheduled for Aug. 6

INmune Bio scheduled a conference call on Aug. 6, 2026 at 4:30 p.m. ET to report Q2 results ended June 30, 2026.

The call will include a corporate update; live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1769234&tp_key=7c277bcdb8.

Replay available through Sept. 21, 2026.

Related News

Gates Industrial raises 2026 adjusted EPS forecast to $1.62-$1.7

GTES•2026-07-31

Guardant Health Inc <GH.O>: BTIG raises target price to $195 from $190

GH•2026-07-31

Floor & Decor Holdings Inc <FND.N>: JP Morgan raises target price to $59 from $46

•

2026-07-31

Datadog Inc <DDOG.O>: D.A. Davidson Raises Target Price to $315 From $250

DDOG•2026-07-31

Elanco releases 2025 Impact Report, ESG disclosures available online

ELAN•2026-07-31